92 related articles for article (PubMed ID: 23974224)
1. Desmoplastic melanoma: expression of epithelial-mesenchymal transition-related proteins.
Garrido MC; Requena L; Kutzner H; Ortiz P; Pérez-Gómez B; Rodriguez-Peralto JL
Am J Dermatopathol; 2014 Mar; 36(3):238-42. PubMed ID: 23974224
[TBL] [Abstract][Full Text] [Related]
2. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
3. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis.
Alonso SR; Tracey L; Ortiz P; Pérez-Gómez B; Palacios J; Pollán M; Linares J; Serrano S; Sáez-Castillo AI; Sánchez L; Pajares R; Sánchez-Aguilera A; Artiga MJ; Piris MA; Rodríguez-Peralto JL
Cancer Res; 2007 Apr; 67(7):3450-60. PubMed ID: 17409456
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas.
Attis MG; Burchette JL; Selim MA; Pham T; Soler AP
Hum Pathol; 2006 Jul; 37(7):899-905. PubMed ID: 16784991
[TBL] [Abstract][Full Text] [Related]
5. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
Leinweber B; Hofmann-Wellenhof R; Kaddu S; McCalmont TH
Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
[TBL] [Abstract][Full Text] [Related]
6. P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.
Lazova R; Tantcheva-Poor I; Sigal AC
J Am Acad Dermatol; 2010 Nov; 63(5):852-8. PubMed ID: 20950740
[TBL] [Abstract][Full Text] [Related]
7. Desmoplastic melanoma: an updated immunohistochemical analysis of 40 cases with a proposal for an additional panel of stains for diagnosis.
Plaza JA; Bonneau P; Prieto V; Sangueza M; Mackinnon A; Suster D; Bacchi C; Estrozi B; Kazakov D; Kacerovska D; Falconieri G; Suster S
J Cutan Pathol; 2016 Apr; 43(4):313-23. PubMed ID: 26661921
[TBL] [Abstract][Full Text] [Related]
8. Cytologic features of metastatic and recurrent melanoma in patients with primary cutaneous desmoplastic melanoma.
Murali R; Loughman NT; McKenzie PR; Watson GF; Thompson JF; Scolyer RA
Am J Clin Pathol; 2008 Nov; 130(5):715-23. PubMed ID: 18854263
[TBL] [Abstract][Full Text] [Related]
9. Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling.
Busam KJ; Zhao H; Coit DG; Kucukgol D; Jungbluth AA; Nobrega J; Viale A
J Invest Dermatol; 2005 Feb; 124(2):412-8. PubMed ID: 15675962
[TBL] [Abstract][Full Text] [Related]
10. Potentially useful markers for desmoplastic melanoma: an analysis of KBA.62, p-AKT, and ezrin.
Bernaba BN; Vogiatzis PI; Binder SW; Cassarino DS
Am J Dermatopathol; 2011 Jun; 33(4):333-7; quiz 338-40. PubMed ID: 21610456
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients.
Murali R; Shaw HM; Lai K; McCarthy SW; Quinn MJ; Stretch JR; Thompson JF; Scolyer RA
Cancer; 2010 Sep; 116(17):4130-8. PubMed ID: 20564101
[TBL] [Abstract][Full Text] [Related]
12. WT 1 expression in nevi and melanomas: a marker of melanocytic invasion into the dermis.
Garrido-Ruiz MC; Rodriguez-Pinilla SM; Pérez-Gómez B; Rodriguez-Peralto JL
J Cutan Pathol; 2010 May; 37(5):542-8. PubMed ID: 19638168
[TBL] [Abstract][Full Text] [Related]
13. Desmoplastic melanoma.
Busam KJ
Clin Lab Med; 2011 Jun; 31(2):321-30. PubMed ID: 21549245
[TBL] [Abstract][Full Text] [Related]
14. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas.
de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G
Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-Mesenchymal Expression Phenotype of Primary Melanoma and Matched Metastases and Relationship with Overall Survival.
Yan S; Holderness BM; Li Z; Seidel GD; Gui J; Fisher JL; Ernstoff MS
Anticancer Res; 2016 Dec; 36(12):6449-6456. PubMed ID: 27919967
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.
Bauer R; Wild PJ; Meyer S; Bataille F; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
J Clin Pathol; 2006 Jul; 59(7):699-705. PubMed ID: 16565225
[TBL] [Abstract][Full Text] [Related]
17. Role of epithelial-mesenchymal transition involved molecules in the progression of cutaneous melanoma.
Murtas D; Maxia C; Diana A; Pilloni L; Corda C; Minerba L; Tomei S; Piras F; Ferreli C; Perra MT
Histochem Cell Biol; 2017 Dec; 148(6):639-649. PubMed ID: 28828681
[TBL] [Abstract][Full Text] [Related]
18. "Combined" desmoplastic melanoma of the vulva with poor clinical outcome.
Collina G
Pathologica; 2011 Dec; 103(6):337-9. PubMed ID: 22558891
[TBL] [Abstract][Full Text] [Related]
19. SOX10 expression distinguishes desmoplastic melanoma from its histologic mimics.
Palla B; Su A; Binder S; Dry S
Am J Dermatopathol; 2013 Jul; 35(5):576-81. PubMed ID: 23291581
[TBL] [Abstract][Full Text] [Related]
20. Desmoplastic melanoma: a diagnostic trap for the unwary.
McCarthy SW; Scolyer RA; Palmer AA
Pathology; 2004 Oct; 36(5):445-51. PubMed ID: 15370114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]